A New Jersey-based drug company is recalling thousands of bottles of medication for high blood pressure after they failed to meet federal quality standards.
The recall affects bottles of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide manufactured by Macleods Pharma USA and distributed nationwide.
It covers 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B; both lots expire 31 May 2027.
You must log in or register to comment.
Doctor who is asked to recall it:
“Ahh yes, I remember that one”.
Well, if Doctor Who is asked to recall it he can simply use the TARDIS to travel back in time
Man, this report really boils my blood.
